Prevention and Early Detection of HPV-associated Anogenital Cancers in Women Living with HIV
Elizabeth A. Stier, MD
Associate Professor, Obstetrics and Gynecology
Director, Dysplasia Services
Boston University Medical Center, Boston, MA
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2019. All rights reserved.
Dr. Elizabeth Stier has lectured nationally and internationally on anal cancer prevention as well as evaluation of the cervix and vulva in women. She has a particular interest in multi-zonal disease in HIV-positive women and has led national multicenter studies investigating the diagnosis and treatment of HSIL of the cervix, vagina, vulva, peri-anus and anal canal. She has been co-chair of the HPV working group in the AIDS Malignancy Consortium (AMC) since 2001, the Boston PI for the ANCHOR study, co-chair of a randomized study of concurrent chemotherapy and pelvic radiation therapy in HIV-infected women, and also working on international AMC trials for the prevention and treatment of cervical cancer in in HIV-infected women in sub-Saharan Africa.
At the completion of this educational session, learners will:
- Know the role of HPV testing in cervical cancer screening in women living with HIV (WLHIV).
- Appreciate the importance of recognizing vulvar and perianal intraepithelial neoplasm (VIN/PAIN) and associated treatment dilemmas.
- Understand how to screen for anal cancer in women-- who and how to screen.
This CME activity has approved for AMA PRA Category 1 Credit™
on October 15, 2019 and will terminate October 14, 2022.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Elizabeth A. Stier (Presenter) had no relevant financial relationships to disclose. Dr. Stier submitted her slides in advance for adequate peer review, and.will support her presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
To obtain CME credit for this PRN program, please visit the PRN Courses Page
at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.